> About Us > Who We Are > H. Thomas Aretz
"Education and learning -- as individuals, teams, organizations, governments and societies -- are essential in the ever-changing world of health care, in order to maintain and constantly improve the health and well-being of individuals and societies."
- Vice President, Global Programs, Partners Harvard Medical International
- Associate Pathologist, Massachusetts General Hospital
- Associate Professor of Pathology, Harvard Medical School
- Design and implementation of academic educational programs internationally
- Strategic planner in academic environs
- Curriculum development and implementation, including faculty development
- Health care policy
- Founding member, The Academy at Harvard Medical School
- Course Director, Harvard Medical School
- Academic practice of cardiovascular pathology, MGH, Harvard Medical School
- Chairman, Institutional Review Board
- Co-founder and director of three medical technology start-ups
- Ehrenbuergerschaft (honorary citizen), Ludwig Maximilians University Munich, Germany
- Vice President for Education, Harvard Medical International
- Australia, Belize, Brazil, Canada, China, Croatia, Dominican Republic, Egypt, France, Germany, Greece, Hong Kong, India, Ireland, Italy, Japan, Korea, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Portugal, Qatar, Saudi Arabia, Singapore, Sweden, Switzerland, Thailand, Turkey, UAE, and United Kingdom
- Harvard Medical School, M.D.
- Massachusetts General Hospital, Postdoctoral Training in Pathology and Cardiovascular Pathology
- American Board of Pathology, Certified in Anatomic and Clinical Pathology
- Thurer R, Aretz HT, Wilkins ML, Younis S, Bishawi AH, Eckhert NL, Armstrong E, Makadon H, Mitchell JD. Facility Design to Support Educational Innovation in a Unique Healthcare Environment. Harvard Medical School Dubai Center Institute for Postgraduate Education and Research and Harvard Medical International.
- Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111:1551-5.
- MacNeill BD, Jang I-K, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, Kauffman CR, Houser SL, Aretz HT DeJoseph D, Halpern EF, Tearney GJ. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-979.
- Tearney GJ, MacNeill B, Jang IK, Ifitimia N, Shishkov M, Houser SL, Aretz HT, Halpern EF, Bouma BE. Coronary plaque macrophage distributions in living patients measured by optical coherence tomography. In: SPIE Conference Photonoics West '04; 2004: paper 5316-11.
- Aretz HT. Problem-based learning -- Is it relevant to clinical education? Medizinische Ausbildung 2003;20:186-193
- Aretz HT. Diagnostic Surgical Pathology, 4th edition. Raven Press, NY, NY. 2003
- Hassink RJ, Aretz HT, Ruskin J, Keane D. Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation. J Am Coll Cardiol. 2003;42:1108-1114
- Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH, Scherrer-Crosbie M. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol. 2004;286:H1070-1075.
- MacNeill B, Jang IK, Bouma BE, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf K, Kauffman CR, Shishkov M, Iftimia N., Halpern EF, Tearney GJ. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. Journal of American College of Cardiology 2004; accepted for publication.
- Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AB, Jacoby DB, Dinsmore JH, Wright S, Aretz HT, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-888
- Planz B, Tabatabaei S, Kirley SD, Aretz HT, Wang Q, Lin CW, McDougal WS, Marberger M. Studies on the differentiation pathway and growth characteristics of epithelial culture cells of the human prostate. Prostate Cancer Prostatic Dis. 2004;7:73-83
- Rubenstein MH, Finn AV, Leinbach RC, Hollenbach S, Aretz HT, Virmani R, Gold HK. Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury. J Am Coll Cardiol. 2004;43:287-294.
